Pharmaceutical

Scientist.com Listed Among Top 50 Healthcare Technology Companies of 2025

R&D orchestration platform recognized for accelerating drug discovery through digital transformation and AI-powered outsourcingSOLANA BEACH, Calif., Nov. 25, 2025 /PRNewswire/…

2 weeks ago

Mastering Inspection Readiness for FDA’s AI Tool Elsa, Upcoming Webinar Hosted by Xtalks

In this free webinar, gain insight into the common risks sponsors face in maintaining quality oversight amid budget and staffing…

2 weeks ago

Overcoming Pharmaceutical Supply Chain Risks with AI Tools, Upcoming Webinar Hosted by Xtalks

In this free webinar, gain insight into the most critical issues faced by pharmaceutical supply chains and how to address…

2 weeks ago

Catalyx Report Reveals Persistent Manufacturing Bottlenecks in Life Sciences Industry

Despite Digital Technology Push, Nearly Two-Thirds of Pharmaceutical and Medical Device Companies Still Rely on Manual Processes for Critical Production…

2 weeks ago

Medical Care Technologies Inc. (OTC Pink:MDCE) Strengthens Foundational AI Infrastructure as Company Prepares for Next Development Milestones

MESA, ARIZONA / ACCESS Newswire / November 25, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) today confirmed that it…

2 weeks ago

Mann Eye Institute Announces Its Holiday Luxury Showcase: An Exclusive Evening of Designer Eyewear

HOUSTON, TEXAS / ACCESS Newswire / November 25, 2025 / Mann Eye Institute is kicking off the season in style…

2 weeks ago

Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference

Live webcast fireside chat on Thursday, December 4th at 10:30 AM ET Carlsbad, CA, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Palisade…

2 weeks ago

Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025

Seven posters to be presented, including new X-TOLE OLE data supporting the ability to attain and regain extended periods of…

2 weeks ago

VSee Health’s iDoc Division Powers Ahead: Delivering on Major Contracts and Igniting Revenue Growth!

SAN JOSE, CALIFORNIA / ACCESS Newswire / November 25, 2025 / VSee Health, Inc. (NASDAQ:VSEE), a leader in innovative telemedicine…

2 weeks ago

Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels in Human Prostate Cancer Cells

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related…

2 weeks ago